Deoxymethoxetamine
Dissociative, Habit-forming, Research-chemical
Deoxymethoxetamine (DXME) is a novel dissociative from the arylcyclohexylamine family that emerged on the illicit market around 2020–2021. It has been identified as a new psychoactive substance and computationally predicted to possess addictive potential. Human pharmacological data remain limited, and effects show notable inter-individual variability.
Oral (exact value unknown).
Unknown.
Please be aware that with research chemicals purchased from grey-market vendors, one can never be 100% certain of the actual amount or purity of the active compound. Tread lightly.
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Strong
Heavy
Oral
15-25mg
30-50mg
50-80mg
80mg+
Onset
Duration
After Effects
Oral
30m to 1h 30m
4 to 8
6 to 24
Dissociation, Analgesia, Euphoria, Cognitive impairment, Sedation, Time distortion, Impaired coordination, Confusion
Han M, Liu S, Zhang D, et al. AddictedChem: A Data-Driven Integrated Platform for New Psychoactive Substance Identification. Front Pharmacol. 2022;13:922741. https://pmc.ncbi.nlm.nih.gov/articles/PMC9227411/